| Report ID |
138654 |
| Drug Identification Number |
02236564 |
| Brand name |
LOVENOX WITH PRESERVATIVE 300MG/3ML |
| Common or Proper name |
Lovenox Vial |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
ENOXAPARIN SODIUM |
| Strength(s) |
100MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
SUBCUTANEOUS
INTRAVENOUS
SUBCUTANEOUS
INTRAVENOUS |
| Packaging size |
1 |
| ATC code |
B01AB |
| ATC description |
ANTITHROMBOTIC AGENTS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2021-12-30 |
| Actual start date |
|
| Estimated end date |
2022-01-06 |
| Actual end date |
2021-12-02 |
| Shortage status |
Avoided shortage |
| Updated date |
2021-12-02 |
| Company comments |
Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
